Olive AI
Healthcare AI unicorn for hospital back-office automation (billing, prior authorization, revenue cycle). Raised $1B, valued at $4B, deployed in 900 hospitals. Shut down Oct 2023.
About
Olive AI was a healthcare automation unicorn that raised over $830M at $4B valuation. Offered AI solutions for hospital back-office: revenue cycle management, prior authorization, and administrative tasks. Deployed in ~900 US hospitals. Suffered from unfocused growth, chasing multiple product lines without operational discipline. Technical bottlenecks and limited demonstrable value led to layoffs in mid-2022 and complete wind-down in October 2023. Business units sold off to other health IT companies.
Business Intelligence
Company
Olive AI
Market Recognition
Well KnownKnown in industry
Momentum
Strongly DecliningCompany Information
Founded
2012
Status
PrivateHeadquarters
Columbus, Ohio
Employees
201-500
Market Position
Market Position
Major PlayerTarget Markets
Primary Competitors
Financial
Funding Stage
Series C+Latest Funding
$400M Series H
Funding Date
2021
Est. Revenue
$100M-$500MCustomer Sentiment & Momentum
Customer Sentiment
NegativeSentiment Notes
Hospital customers frustrated by implementation challenges and limited ROI. Internal confusion about product strategy. Promised more than could deliver.
Momentum Analysis
Unicorn to shutdown in 2 years. Raised $830M+ at $4B valuation. Expanded too quickly across multiple product lines. 665 employees laid off July 2022-Feb 2023. Complete wind-down Oct 2023. Classic case of unfocused hypergrowth.
Competitive Intelligence
Strengths
- ✓Large customer base (900 hospitals)
- ✓Significant funding
- ✓Healthcare domain expertise
Weaknesses
- ⚠Unfocused expansion
- ⚠Operational inefficiency
- ⚠Limited demonstrable ROI
- ⚠Technical bottlenecks
- ⚠Shutdown 2023